Understanding and managing refractory CIDP

Episode 6. Mark Stettner and Karissa Gable discuss the real-world challenges of managing refractory CIDP, from defining meaningful treatment response to recognizing when stability is no longer sufficient. Drawing on recent clinical trial findings and evolving insights into CIDP pathophysiology, they explore decision-making beyond first-line therapies and what current evidence can – and cannot – tell us about long-term care.